Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed May 20, 2013 · 10-Q · 50 days after period end · 0001354488-13-003018
| Metric | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|
| Net Income | -$337.67K | -$3.10M | -$508.44K |
| EPS Diluted | $0.00 | -$0.04 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 20, 2013 · 50 d after period end
